Oorsprong van het eerstegraads netwerk van Patrice Sellès
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
15
| Public Company | Chemicals: Agricultural | 15 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Patrice Sellès via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
| BASF SE | Chemicals: Major Diversified | Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member | |
| Government of Germany | Sovereign | President | |
| K+S AG | Chemicals: Specialty | Director/Board Member | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
BASF Corp.
 BASF Corp. Chemicals: Major DiversifiedProcess Industries BASF Corp. manufactures commercial and industrial chemicals. The firm serves the aerospace, agriculture, automotive, clean energy, nutrition, textiles, and building, and construction sectors. The company was founded in 1986 and is headquartered Florham Park, NJ. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| University of Cambridge | College/University | Corporate Officer/Principal | |
| John Carroll University | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Corporate Officer/Principal | |
BASF SA
 BASF SA Chemicals: Major DiversifiedProcess Industries Part of BASF SE, BASF SA is a Brazilian company that manufactures chemicals, paints, agricultural products and others. The private company is based in São Paulo, Brazil. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Corporate Officer/Principal | |
| ABLYNX | Biotechnology | Director of Finance/CFO Director/Board Member | |
Commonwealth Scientific & Industrial Research Organisation
 Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Agrium U.S., Inc.
 Agrium U.S., Inc. Chemicals: AgriculturalProcess Industries Agrium US, Inc. produces and distributes fertilizers such as nitrogen, phosphate, potash and ulfate. The firm distributes agricultural products, services and nutrients for agricultural and industrial markets. It offers a range of liquid and dry fertilizer products including insecticides and fungicides, as well as seeds that include corn, soybeans, cotton, canola and alfalfa. The company is located in Denver, CO | Chemicals: Agricultural | Sales & Marketing | |
| Ghent University | College/University | Chief Operating Officer | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
| Universidad Argentina de la Empresa | College/University | Undergraduate Degree | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| Université Libre de Bruxelles | College/University | Graduate Degree | |
| Waikato University | College/University | Graduate Degree | |
| Universidad del CEMA | College/University | Masters Business Admin | |
Shell International Ltd.
 Shell International Ltd. Miscellaneous Commercial ServicesCommercial Services Shell International Ltd. provides business support services. It engages in upstream and downstream oil and gas businesses in the United Kingdom and internationally. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
K+S Minerals & Agriculture GmbH
 K+S Minerals & Agriculture GmbH Chemicals: AgriculturalProcess Industries K+S Minerals & Agriculture GmbH operate as a mining company. It offers soil conditioners, as well as liquid and foliar fertilizers. The company is headquartered in Kassel, Germany. | Chemicals: Agricultural | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree | |
STJ Advisors LLP
 STJ Advisors LLP Investment ManagersFinance STJ Advisors LLP provides capital markets advisory services. The private company is based in London, UK and has subsidiaries in Hong Kong. The British company was founded in 2008 by John James Moore St. John. | Investment Managers | Corporate Officer/Principal | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
| Creabilis SA | Director/Board Member | ||
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The private company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 10 |
| Verenigde Staten | 8 |
| Zwitserland | 7 |
| België | 7 |
| Duitsland | 6 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 14 |
| Process Industries | 8 |
| Finance | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 32 |
| Corporate Officer/Principal | 28 |
| Independent Dir/Board Member | 16 |
| Director of Finance/CFO | 7 |
| Graduate Degree | 7 |
Sterkste connecties
| Insiders | |
|---|---|
| Catherine Moukheibir | 29 |
| Simon Moroney | 11 |
| Luc Basstanie | 11 |
| Kevin R. Helash | 10 |
| Wim Ottevaere | 7 |
| Markus Heldt | 7 |
| Luc Maertens | 4 |
| Diego Angelo | 3 |
| Michiel van Lookeren Campagne | 3 |
| Patrick McDonnell | 2 |
| Carlo Boutton | 2 |
| Mike Stepan | 1 |
| Douglas Minder | 1 |
| Eva van Hende | 1 |
| Sophie Snijders | 1 |
- Beurs
- Insiders
- Patrice Sellès
- Bedrijfsconnecties
